PDA

View Full Version : Articles of Interest

Pages : 1 2 3 4 5 6 7 8 9 10 11 12 13 [14] 15 16 17 18
  1. Axillary Dissection Unnecessary in Select Small Breast Cancers
  2. 17 Years Later, Stage 4 Survivor Is Savoring a Life Well Lived
  3. Impact of a chemoresponse assay on treatment costs for recurrent ovarian cancer
  4. Vitamin D supplements and breast cancer risk
  5. Important study of breast mri
  6. Genomic Analyses of No. of gene copy changes in Her2+ bc
  7. Estrogen receptor status of HER2+ breast cancer correlates with response to anti-HER
  8. researchers study why cells stop clinging and spead
  9. Inhibition of C (PC-PLC) downregulates Her2 on bc cell membranes
  10. Adjuvant Hormonal Therapy in Premenopausal Women - perspectives
  11. AKT a molecular pathway - a popular target for cancer drug therapies
  12. concerns of radiation
  13. Prenatal Exposure To Endocrine-Disrupting Chemicals Linked To Breast Cancer
  14. Update on use of AIs in early bc
  15. Inactivation of C(PC-PLC) downregulates Her2
  16. What do we learn from Her2+ genomic profiles?
  17. Bilateral mastectomies rising
  18. Post-mastectomy anesthesia may affect recurrence
  19. Breast Cancer: Environmental Risks Don't Interact With Gene Risks
  20. Relationship of thyroid hormone T3 to breast cancer
  21. Exploring the Interface between Cancer and Psychiatry
  22. Epithelial to mesenchymal transition and breast cancer
  23. Toothbrushing Less Than Twice a Day Linked to Increased CV Risk
  24. Activism among exceptional patients with cancer.
  25. Personalized treatment trial for early-stage BC
  26. Slideshow: Top Cancer-Fighting Foods
  27. How Chemotherapy affects Maximal Std Uptake Volume in PET scans
  28. Wnt and ILK signaling accelerate bc tumor development
  29. Dynamic changes in gene expression in vivo in tamoxifen treated pts
  30. P13K pathway activity linked to lower ER in ER+ BC
  31. From the NEJM: Is Computed Tomography Safe?
  32. Fulvestrant has the potential to improve taxane sensitivity in ER+ bc cells
  33. Weight-bearing Exercise & Bone Metabolism among BC survivors
  34. Rhodiola
  35. Key Players in Oxidative Stress Control in BC Negatively Influenced by Her2+
  36. Tamoxifen enhances the cytotoxic effects of nelfinavir
  37. SSRI drugs maybe not a problem with Tamoxifen?
  38. Tumor senescence and radioresistant tumor-initiating cells
  39. HER3 and downstream pathways are involved in colonization of brain
  40. From MD Anderson: Delayed Onset of "Chemo Brain" Months After Treatment
  41. Effect of Body Mass Index on Recurrences in Tamoxifen and Anastrozole Treated Women
  42. Anastrazole Effect Lessened with Increased BMI
  43. CMF more effective in TN than Her2+ BC
  44. 'Less Is More' in Local Therapy for Early-Stage Breast Cancer
  45. Use of Nolvadex in the Treatment of Generic Tamoxifen-Associated Small Joint Arthralg
  46. Biopsy and Pathology issues
  47. Esoteric Article for those interested in anthropology or marketing
  48. Fish Oil Reduces BC Risk by 32%
  49. Are hospitals deadlier in July?
  50. Betulinic Acid (Birch)
  51. Profiles of exposure: Health care workers share lessons
  52. Role of B7-H1 as an anti-apoptotic molecule
  53. Gonadotropin releasing hormone typ II antagonist induces death in ER+ & ER- bc cells
  54. Many physicians don't want to rat on each other
  55. Gene C35 That Causes HER2 Breast Cancer To Spread Raises Hope For New Treatment
  56. Neoadjuvant Femara study highlights heterogeneity of response to AI
  57. Earliest Steps to Find Breast Cancer Are Prone to Error
  58. NR4A1 reduces the migration of normal and breast cancer cell lines
  59. Avastin's Last Hope For Breast Cancer Claim May Be Subpopulations
  60. Increased risk with progestin use
  61. HOXB13 levels correlates to Her2+ and predicts Tamoxifen response
  62. Concern for the peril of personal-care products
  63. ImmunoRatio: a publicly available web application for quantitative analysis of ER, PR
  64. MYB suppresses differentiation and apoptosis of human breast cancer cells
  65. Gene-Guided Chemotherapy Research Questioned
  66. A new 'function' related treatment method
  67. ASCO Update on Adjuvant Endocrine Therapy
  68. Anti tumor effects of retinoids combined with trastuzumab or tamoxifen
  69. Research Shows Patients May Live Longer with Hospice and Palliative Care
  70. Air travel and lymphedema - another small study
  71. UA 2010 - Is Prostate Cancer an Infectious Disease?
  72. Dermatologic Toxicities of Targeted Anticancer Drugs
  73. Mm-111
  74. Drug Success Against Malignant Melanoma.
  75. RNAi therapy
  76. Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer
  77. Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for MBC
  78. Conditional Survival Among Cancer Patients in the United States
  79. hope in new techniques.
  80. Viral therapies
  81. Long Term Use of Oral Bisphosphonates May Double Risk of Esophageal Cancer
  82. Breast cancer genetics - LBBC
  83. Provocative and Thought Provoking Opinion Piece from the NEJM
  84. Antiozidant Rich foods
  85. bc treatment followed by metabolic syndrome
  86. Antidepressant Pretreatment and Chemotherapy (and role of inflammation)
  87. Provenge: implications for measuring effectiveness
  88. Immutep Results In Phase I/II Chemoimmunotherapy (ImmuFact(R) IMP321) In MBC
  89. Interesting physician blog on breast cancer
  90. Treating Cancer Based on Its Genome
  91. Physical or Psychological Stress May Weaken Cancer Therapy
  92. Receptor Conversion in Distant BC Mets
  93. Collaborative explorations to study sarcoma as behavior model for other cancers
  94. Radiotherapy as palliative treatment of pain for bone mets
  95. Bone marrow procedures move into the 21st century
  96. Push it, pull it, drag it, throw it, carry it, walk it, run it, bike it
  97. Baby Boomers Leading Charge for Medical Tourism Trends
  98. DNA methylation epigenotypes in breast cancer molecular subtypes
  99. new study
  100. 10 year Survival Stats Leap ahead over Last 50 Years
  101. Cancer researchers testing radical change in drug trials
  102. Long-Term Breast Radiotherapy Trials at Odds Over Risk of Second Malignancies
  103. For those interested in a cure
  104. Private Insurers, efforts to Ration Health Care
  105. Devastating Blow to Cancer Patients?
  106. Soy intake associated with lower recurrence of breast cancer in hormone-sensitive can
  107. The Role of Fatty Acids in Mammary Gland Development and BC
  108. Green Tea Drinking and Breast Cancer+
  109. Cure mag:"Are metastatic patients getting the right TX?"
  110. Bogus Breast Cancer Research (Why the Little Pink Ribbon Has Me Seeing Red)
  111. Full of Beans
  112. Effects of soy on her2 positive cancer?
  113. 'Nano-Drug' Hits Brain-Tumor Target: Unique Triggering Device Delivers Antitumor Drug
  114. Safe and effective radiosurgery - UCLA
  115. Inflammatory Breast Cancer Articles/Clinical Trials
  116. Chemoprevention Biomarker For Breast Cancer Identified
  117. Researches create metastatic bc stem-like cells by manipulating oxygen environment
  118. Genome wide association scan for ER- bc
  119. Studying changes in biomarker status at bc progression
  120. Improving Optical BC surgery margin assessment
  121. Fatty Acid Synthase phospholorylation is a target for Her+ bc tx
  122. MRI's superior in dx BRCA1 & 2 BC
  123. An Oncologist Writes "A Biography of Cancer"
  124. Lifetime risks of bc subgroups based on ethnicity
  125. Study on Premeno testosterone levels and bc risk
  126. Xl184
  127. P53 gene
  128. Cough syrup gives clue to Tamoxifen drug dose
  129. Breast Cancer Chemotherpay Treatment
  130. Fuel Lines of Tumors Are New Target
  131. Women with small tumors/node neg.
  132. New study on stage 1
  133. Amenorrhea from Breast Cancer Therapy related to outcomes
  134. Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer
  135. The Aftermath of 2009 Mammogram Guidelines
  136. Personal Breast Cancer History: Screening MRI, Annual Mammography Recommended
  137. Add Taxane to Adjuvant Chemo for Early, Node-Negative Breast Cancer
  138. Long Term Aspirin Use Cuts Cancer Death Rates
  139. (BCIRG 007 Study): Two Highly Active Therapeutic Regimens
  140. Does tumor size trump biology
  141. When Scientific 'Breakthroughs' Get Lost in Translation
  142. Trastuzumab/Pertuzumab Doublet Eradicates Some Early Breast Cancer
  143. Review Suggests Benefits in Estrogen
  144. Surgical Excision Can Spread Tumor Cells to Sentinel Node
  145. Better Imaging Doesn't Always Mean Better Diagnosis, Expert Says
  146. Dual Anti-HER2 Blockade Called the Future of Breast Cancer Therapy
  147. Study on the role of Melatonin in regulating bc cell invasion
  148. A Breast Oncologist, Diagnosed With The Disease
  149. New guidelines for ER/PR testing to ensure accuracy
  150. Cancer: Eat me
  151. Clinical trials for Circulating Tumor Cells
  152. 6 Cycles of chemo no better than 4 in bc pts with 0-3 positive nodes
  153. Flawed research appalls cancer patient
  154. Cancer Can Develop in Catastrophic Burst
  155. Effectiveness of MRI for neoadjuvant therapy for HER2 monitoring
  156. Manual Drainage Fails to Prevent Lymphedema in Breast Cancer Patients
  157. FDA to alter rules for cancer drug cocktails
  158. Cure magazine...progress and promise
  159. Effect of Occult Metastases on Survival in Node-Negative Breast Cancer
  160. RAD21 protein predictive of poor prognosis in grade 3 bc
  161. minimal prognostic or survival rate value in analysing sentinel lymph node tissue for
  162. Breast Cancer Stem Cells: A New Target for Therapy
  163. Probing the mind's role in hot flashes
  164. Fatty Acid Synthase May Predict Molecular Functioning of Tykerb
  165. Novel Effort To Fight Cancer With Cancer Cells
  166. Avastin - Explanation
  167. ER/PR positive status related to loss of a protein that fends off aging
  168. Statins may increase Tamoxifen sensitivity in pre-meno women
  169. Multi-Targeted Therapy Is Extending Non-Chemotherapy Options for MBC
  170. US NIH/U of Hong Kong - protein level predicts cancer spread
  171. MRI monitoring during neoadjuvant therapy dependent on bc type
  172. Research on gene amplification associated with Her2
  173. Heat Shock Protein helps bc cells fool immune system
  174. The “Smart Bomb” of Tomorrow – Eradicating Cancer (multiplying T cells)
  175. need this for cancer..............
  176. Study on a new Her2 vaccine showing promise in mice
  177. Pioneer in Cancer Survivorship Honored
  178. mTOR inhib + TKI in neuroendo panc, impications for BC?
  179. Assessing gynecologic and breast cancer survivors' sexual health care needs
  180. How Long Have I Had My Cancer, Doctor?
  181. Skin Conditions Can Have Severe Impact in Cancer Patients
  182. Oz Radio: Fighting for the rights of breast cancer patients
  183. Gene Mutation Key To Ecuador Group's Health
  184. Cancer Drugs Have Worst Phase III Track Record
  185. Breast Research Urges Needle, Not Surgical, Biopsies
  186. researchers uncover pathway of
  187. Novel Methods...speeding up the process
  188. Sexual issues and informed consent
  189. Bedside/PCP detection of tumor cells
  190. Gene to be studied which destroys breast cancer cells
  191. Bilateral Breast Cancer: Analysis of Incidence, Outcome, Survival and Disease Charact
  192. Cancer Therapy Associated Bone Loss: Implications for Hip Fractures in Mid-Life Women
  193. New class of drugs show promise for ER+ endocrine therapy reisistant bc
  194. The ClinicalTrials.gov Results Database — Update and Key Issues
  195. Unrealistic Optimism and Ethics in Stage I Clinical Trials
  196. Hit multiple targets for maximum benefit in HER2-positive breast cancer, studies sugg
  197. Results of Utility of Long-term Herceptin Use After Adjuvant Chemotherapy
  198. Study on the Effect of Fulvestrant in triple positive BC
  199. Research Groups Ally as NCI Clinical Trials Program Begins Seismic Shift
  200. Parity Tied to Triple Negative Breast Cancer
  201. Breast cancer may not change lifespan for older women
  202. Local Immune Response Predictive of Cancer Prognosis
  203. TDM1 Associate Marketing Director Position
  204. Breast Cancer Survivors and Patients Exercising, Healing Together
  205. NE study seeks women who have been diagnosed with breast cancer
  206. Proposed law change to alleviate declining Medicare reimbursements
  207. EGFR Status May Explain Depression-Survival Link in NSCLC
  208. Eribulin Shows Improved Overall Survival in Late-Stage Aggressive Metastatic BC
  209. Marking a New Pathway for Hormone-Resistant Breast Cancer Treatment
  210. Clinical Trial Participation Tied to Improved Breast Cancer Outcomes
  211. Clinically Significant Distress Seen in 12.6% of Cancer Patients
  212. More from the blog of the doctor whose wife has cancer
  213. Metformin trials discussion
  214. Autophagy and HER2 researcher
  215. FDA Perspective on Developing Novel Combination Therapies
  216. New Class of Cancer Drugs Focus on Immune System
  217. Combination of MEK/ERK Inhibitor and mTOR/P13K Inhibitor
  218. Metastices may change from original her2..
  219. Fast-Tracking Oncology Drugs Questioned?
  220. Hallmarks of Cancer: The Next Generation
  221. Teaching Clinicians about Drugs — 50 Years Later, Whose Job Is It?
  222. Adipokines, insulin resistance, metabolic syndrome, and recurrence
  223. study hoping to uncover....
  224. study in finding early stage bc .....in breast milk.
  225. From JAMA: Health Outcomes for post-meno, hysterectomized women on Premarin
  226. Effect of loss of progesterone with hysterectomy
  227. ALM 201: Peptide Inhibitor of Angiogenesis
  228. The Women’s Health Initiative and the Body Politic
  229. Nanobody proves effective in trials...
  230. Fish oil study
  231. ER beta, Her2/Her3 & tamoxifen
  232. IL25 and other proteins secreted by normal breast cells that kill or subdue their mut
  233. Topical Testosterone for Breast Cancer Patients with Vaginal Atrophy Related to AIs
  234. Breast Cancer Prognosis Goes High Tech
  235. Does Her2+ DCIS progress to Her2- IDC?
  236. Living with the legacy of breast cancer
  237. Paper examining how TDM-1 works
  238. Nontoxic Goiter Tied to Higher Risk of Breast Cancer
  239. HER2-Targeted Therapies: How Far We've Come—and Where We’re Headed
  240. Chronic Inflammation and Cancer: The Role of the Mitochondria
  241. Hair growth after herceptin
  242. Listening to Provenge — What a Costly Cancer Treatment Says about Future Medicare Pol
  243. Mixed Recurrence Outcomes When Radiation Is Added to Excision for DCIS
  244. Newgene test for hereditary bc
  245. Insulin-like growth factor 1 behind endorcrine tx resistance
  246. Endocrine resistance in breast cancer: new roles for ErbB3 & ErbB4
  247. Synergy between Herceptin & Tykerb
  248. Sequencing of Postmastectomy Radiotherapy & Breast Reconstruction & Rate of Complicat
  249. Antiangiogenic therapy for breast cancer
  250. Prescriptions, Privacy, and the First Amendment